Data from 1,028 people vaccinated with TAK-003 in Catalonia suggests the dengue vaccine has a good tolerability profile in ...

Citing information from the Department of Health (DOH), Malacañang on Tuesday said the application for a new dengue vaccine ...

MANILA, Philippines — The proposed new generation anti-dengue vaccine remains under review by the Food and Drug ...

Data from 1,028 people vaccinated with TAK-003 in Catalonia suggests that the dengue vaccine has a good tolerability profile in routine clinical practice among travelers from regions where dengue is ...

Dengue fever, caused by a flavivirus named DENV, is a major global health challenge, risking almost half of the world's population. Since the early 20th century, the scientific community has faced ...

DESPITE the controversy involving dengue vaccines in the past, the Philippine Medical Association (PMA) said it will not oppose the return of the dengue vaccine ...

In a recent study published in the journal The Lancet Infectious Diseases, researchers conducted a prospective, longitudinal, population-based cohort study in two communities in the Philippines to ...

Add Yahoo as a preferred source to see more of our stories on Google. Takeda Pharmaceutical Co's logo is seen at its new headquarters in Tokyo (Reuters) -The World Health Organization (WHO) said on ...

The current tetravalent dengue vaccine TAK-003, from the Japanese laboratory Takeda, is not likely to control the ongoing epidemic, according to the Pan American Health Organization (PAHO). The ...

"Animals immunized with the immunogens we designed around the HYFT®-identified target generated antibody responses that recognized antigens from all four dengue serotypes, while scrambled-control ...

WuXi Vaccines, a wholly-owned subsidiary of WuXi Biologics, dedicated to vaccine Contract Development and Manufacturing Organization (CDMO), announced today that its drug substance ...